More paranoia and crazy conspiracy theories.
CUV is just a one trick pony with an overpriced orphan drug. If alpha-MSH analogues showed any real promise BIg Pharma would have been all over them decades ago.Yet only two very obscure drugs for rare conditions have ever been developed. In both cases the companies have been microcaps on the fringe of the dug industry.
Ann: Media release - First stroke patient with afamelanotide, page-24
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.68 |
Change
-0.240(1.61%) |
Mkt cap ! $735.1M | |||
| Open | High | Low | Value | Volume |
| $14.75 | $14.92 | $14.65 | $503.5K | 34.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 448 | $14.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.74 | 149 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |